[1]陈继玲,任珍珍,王劭敏,等.玉泉丸合生脉散联合二甲双胍治疗气阴两虚证2型糖尿病临床研究[J].陕西中医,2021,(11):1553-1556.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.013]
　CHEN Jiling,REN Zhenzhen,WANG Shaomin,et al.Efficacy of Yuquan pills with Shengmai powder and metformin tablets in the treatment of T2DM with deficiency of Qi and Yin[J].,2021,(11):1553-1556.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.013]
点击复制

玉泉丸合生脉散联合二甲双胍治疗气阴两虚证2型糖尿病临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年11期
页码:
1553-1556
栏目:
临床研究
出版日期:
2021-11-05

文章信息/Info

Title:
Efficacy of Yuquan pills with Shengmai powder and metformin tablets in the treatment of T2DM with deficiency of Qi and Yin
作者:
陈继玲; 任珍珍; 王劭敏; 李园园; 张亚丽
(亳州市中医院,安徽 亳州 236800)
Author(s):
CHEN Jiling; REN Zhenzhen; WANG Shaomin; LI Yuanyuan; ZHANG Yali
(Bozhou Hospital of Traditional Chinese Medicine,Bozhou 236800,China)
关键词:
2型糖尿病;  气阴两虚证;  玉泉丸合生脉散;  心血管主要危险因素;  中医症候评分
Keywords:
Type 2 diabetes;  Qi and Yin deficiency syndrome;  Yuquan pill and Shengmai powder;  Main cardiovascular risk factors;  Chinese medicine syndrome score
分类号:
R 587.1
DOI:
DOI:10.3969/j.issn.1000-7369.2020.11.013
文献标志码:
A
摘要:
目的:探究玉泉丸合生脉散联合二甲双胍片治疗气阴两虚证2型糖尿病(T2DM)的疗效及心血管主要危险因素的影响。方法:选择104例气阴两虚证T2DM患者,依照随机数字表法分为两组,各52例。研究组在对照组的基础上采用玉泉丸合生脉散治疗,对照组采用盐酸二甲双胍片治疗,两组均治疗4周。观察两组治疗前后气阴两虚证中医症候评分、糖代谢指标,比较两组弗明汉高危危险评分(FRS)、临床疗效以及治疗期间不良反应发生情况。结果:治疗前,两组空腹血糖(PBG)、糖化血红蛋白(HbAlc)、餐后2 h血糖(2hPBG)水平比较差异无统计学意义(均P>0.05); 两组治疗后,2hPBG、HbAlc水平均低于治疗前(均P<0.05),且研究组更低(P<0.05)。两组治疗后的气阴两虚证中医症候评分比治疗前低(P<0.05),且研究组更低(P<0.05); 研究组中高危FRS心血管主要危险因素发生率比对照组低(P<0.05); 研究组总有效率比对照组高(P<0.05); 两组患者用药期间不良反应比较,差异无统计学意义(P>0.05)。结论:玉泉丸合生脉散联合二甲双胍片治疗气阴两虚证T2DM患者,可改善患者的临床症状,调节糖代谢,减少中高危FRS心血管主要危险因素发生率。
Abstract:
Objective:To explore the efficacy of Yuquan pills and Shengmai powder combined with metformin tablets in the treatment of type 2 diabetes(T2DM)with deficiency of both Qi and Yin and the influence of major cardiovascular risk factors.Methods:A total of 104 T2DM patients with Qi and Yin deficiency syndrome were selected and divided into 2 groups according to the random number method,with 52 cases in each group.The study group was treated with Yuquan pills and Shengmai powder on the basis of the control group,and the control group was treated with metformin hydrochloride tablets.Both groups were treated for 4 weeks.The Chinese medicine syndrome scores and glucose metabolism indexes of the two groups were compared before and after treatment.The main cardiovascular risk factors,clinical efficacy and adverse reactions during the treatment period of the two groups of Framingham high risk risk(FRS)were compared.Results:Before treatment,there was no significant difference in fasting blood glucose(PBG),glycosylated hemoglobin(HbAlc)content,and postprandial 2 h blood glucose(2hPBG)content between the two groups(P>0.05).After treatment,the levels of 2hPBG and HbAlc in the two groups were lower than before treatment(P<0.05)and lower in the study group(P<0.05).The Chinese medicine syndrome scores of the two groups after treatment were lower than those before the treatment(P<0.05),and the study group lower(P<0.05).The incidence of major cardiovascular risk factors for high-risk FRS in the study group was lower than that in the control group(P<0.05).The total effective rate of the control group is lower than that of the study group(P<0.05).There was no statistically significant difference in the adverse reactions between the two groups of patients during the medication period(P>0.05).Conclusion:Yuquan pill combined with Shengmai powder combined with metformin tablets in the treatment of T2DM patients with deficiency of both Qi and Yin has a significant effect.It can improve patients' clinical symptoms,regulate glucose metabolism,reduce the incidence of major cardiovascular risk factors for medium and high-risk FRS.

参考文献/References:

[1] Srikanth V,Sinclair AJ,Briggs F,et al.Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities[J].Lancet Diabetes Endocrinol,2020,8(6):535-545.
[2] Pearson ER.Type 2 diabetes:A multifaceted disease[J].Diabetologia,2019,62(7):1107-1112.
[3] Sacerdote A,Dave P,Lokshin V,et al.Type 2 diabetes mellitus,insulin resistance,and vitamin D[J].Curr Diab Rep,2019,19(10):101.
[4] 付 平,汤 蕾.新型降糖药在2型糖尿病合并慢性肾脏病患者中的临床应用及卫生经济学评价[J].西部医学,2021,33(2):157-162.
[5] 陈 斌,张 苍.中医三联疗法治疗2型糖尿病患者的临床效果研究[J].实用临床医药杂志,2019,23(5):20-22,26.
[6] 王 晶,汪晓敏,王晓平,等.半夏泻心汤对2型糖尿病(脾弱胃强证)患者血糖及胰岛β细胞功能的影响[J].成都中医药大学学报,2021,44(1):81-85.
[7] 肖东英,王晓航,梁 驰,等.玉泉丸联合沙格列汀治疗老年2型糖尿病的临床研究[J].现代药物与临床,2021,36(1):100-105.
[8] 李 梅,李文博.生脉散汤剂治疗2型糖尿病气阴两虚证合并冠心病心绞痛患者的效果观察[J].实用临床医药杂志,2020,24(12):77-79,83.
[9] 张艳青,何友权.血清尿酸水平与2型糖尿病患者心血管疾病发病的相关性[J].中国急救复苏与灾害医学杂志,2020,15(3):291-294.
[10] 国家食品药品监督管理总局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:258-259.
[11] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.
[12] 张雪莲,袁申元,万 钢,等.2926例2型糖尿病患者社区综合干预9年心血管风险的变化[J].中国全科医学,2021,24(10):1242-1248.
[13] 蔡宝石,李 玲,李 梅,等.血府逐瘀汤联合双胍类降糖药治疗糖尿病疗效研究[J].陕西中医,2020,41(6):774-776,789.
[14] 杨菲飞,张 聪,陈 鑫,等.无锡市梁溪区2型糖尿病年发病率变化趋势及预测[J].华南预防医学,2021,47(3):363-366.
[15] 汪会琴,胡如英,武海滨,等.2型糖尿病报告发病率研究进展[J].浙江预防医学,2016,13(1):37-39,57.
[16] 马 明,谢华宁,张军茹.达格列净治疗2型糖尿病合并慢性心力衰竭临床疗效观察[J].陕西医学杂志,2021,50(1):93-95,99.
[17] 倪 青,倪炎炎,张美珍,等.葛根芩连汤加减治疗胃肠湿热型老年2型糖尿病的疗效观察[J].疑难病杂志,2021,20(6):569-573.
[18] 潘赏赏,李 力,王 娴.黄连温胆汤联合盐酸二甲双胍对湿热内蕴型早期2型糖尿病患者的临床疗效[J].中成药,2021,43(2):557-559.
[19] 贾晓岳,张育军,段玉红,等.少腹逐瘀汤联合西地那非治疗气滞血瘀型2型糖尿病性勃起功能障碍疗效观察[J].现代中西医结合杂志,2021,30(9):931-935.
[20] 夏 静,王海明,沈金花,等.参芪麦味地黄汤联合二甲双胍对气阴两虚型2型糖尿病患者UACR、MODD及血流动力学的影响[J].中医药学报,2020,48(2):12-16.
[21] 朱世飞,周里钢.2型糖尿病合并银屑病研究进展[J].辽宁中医药大学学报,2019,21(4):80-83.
[22] 万 红,燕树勋,闫 诏.玉泉丸联合达格列净治疗2型糖尿病的临床研究[J].现代药物与临床,2021,36(2):274-278.
[23] 梅 超,张 玲,张莎莎.生脉散合六味地黄汤治疗气阴两虚型2型糖尿病临床研究[J].新中医,2019,51(7):93-96.
[24] 宋志龙,林奕凯.基于网络药理学研究六昧地黄丸干预二型糖尿病作用机制[J].中国药师,2020,23(11):2151-2155,2183.
[25] 廖禹程,孙 莲,翁 琰,等.基于网络药理学探讨麦冬对心脑血管疾病的潜在药理作用靶点[J].中国药师,2020,23(12):2301-2305,2316.
[26] 李艳红,黎 艳,王亚兰,等.玉泉丸合桃红四物汤加减对气阴两虚证2型糖尿病心血管主要危险因素的影响[J].中国实验方剂学杂志,2020,26(19):177-182.
[27] 刘 鑫,曲 超,王姝婷,等.基于数据挖掘的中药治疗2型糖尿病用药规律分析[J].中华中医药学刊,2020,38(5):74-78.

相似文献/References:

[1]李向辉,卢文杰.葛黄降糖汤治疗2型糖尿病合并颈动脉硬化临床研究*[J].陕西中医,2019,(5):580.
　LI Xianghui,LU Wenjie..Effect of Gehuang Jiangtang decoction on mellitus complicated with carotid arteriosclerosis in type 2 diabetes patients[J].,2019,(11):580.
[2]杨斯皓,马方霞,詹 云.一贯煎合六味地黄汤配合西药治疗2型糖尿病合并非酒精性脂肪肝临床疗效及对患者生活质量的评价*[J].陕西中医,2019,(8):1006.
　YANG Sihao,MA Fangxia,ZHAN Yun..Clinical efficacy and quality of life evaluation of Yiguanjian plus Liuwei Dihuang decoction with western medicine in the treatment of type 2 diabetes with nonalcoholic fatty liver disease[J].,2019,(11):1006.
[3]孙晓红,陈学彬△.芪精丹兰汤对伴有左心室舒张功能不全的2型糖尿病合并代谢综合征患者糖脂代谢、心率变异性的影响*[J].陕西中医,2019,(10):1336.
　SUN Xiaohong,CHEN Xuebin..Effect of Qijing Danlan decoction on glucose and lipid metabolism and heart rate variability in patients with type 2 diabetes mellitus complicated with MS with left ventricular diastolic dysfunction[J].,2019,(11):1336.
[4]訾 璐,胡小军△,王 玉,等.针刺中脘穴联合自拟茶方对2型糖尿病患者血糖水平的影响*[J].陕西中医,2019,(10):1460.
　ZI Lu,HU Xiaojun,WANG Yu,et al.Effect of zhong wan acupuncture combined with selfdesigned tea prescription on blood glucose level in patients with type 2 diabetes mellitus[J].,2019,(11):1460.
[5]文启友,周 伶,马若梦,等.化瘀利尿法论治2型糖尿病探析[J].陕西中医,2021,(6):761.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.021]
[6]谢兆桃,周卓宁,郑 鹏,等.从中焦论治2型糖尿病患者餐后血糖波动[J].陕西中医,2021,(6):764.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.022]
[7]胡全穗,伍宗明.运用中药药对配伍优化消渴病中医防治方案临床研究[J].陕西中医,2021,(8):1084.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.024]
　HU Quansui,WU Zongming.Clinical research on optimizing the TCM prevention and treatment of Xiaoke by using compatibility of herb-partners[J].,2021,(11):1084.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.024]
[8]卢 昉,刘晓霞,梁佩玲,等.清热益气降糖方对2型糖尿病患者胰岛α、β细胞功能的影响[J].陕西中医,2021,(10):1400.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.019]
[9]刘厚利,呼兴华,何 莉,等.基于数据挖掘许建秦治疗湿热内蕴型糖尿病用药规律分析[J].陕西中医,2021,(10):1455.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.035]
[10]李慧敏,李鹏辉,吉兰洁,等.连术消渴颗粒对2型糖尿病模型大鼠肠道菌群、肠黏膜屏障功能及水通道蛋白的影响[J].陕西中医,2021,(12):1663.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.002]
　LI Huimin,LI Penghui,JI Lanjie,et al.Effect of Lianzhu Xiaoke granule on intestinal flora,intestinal mucosal barrier function and aquaporin in type 2 diabetes model rats[J].,2021,(11):1663.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.002]
[11]钱冬梅,陶小琴,丁仁华,等.参芪地黄汤加减治疗糖尿病气阴两虚证疗效及对患者炎症指标与免疫功能的影响[J].陕西中医,2022,(4):469.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.014]
[12]杨川洲,彭艳文,李卫东,等.三才封髓丹加减治疗气阴两虚型2型糖尿病合并汗证疗效研究[J].陕西中医,2022,(9):1204.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.011]
　YANG Chuanzhou,PENG Yanwen,LI Weidong,et al.Clinical study on Sancai Fengsui Dan on type 2 diabetes complicated with sweat syndrome with Qiyin Liangxu[J].,2022,(11):1204.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.011]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(31501103)
更新日期/Last Update: 2021-11-10